Cargando…
Claudin 10 acts as a novel biomarker for the prognosis of patients with ovarian cancer
Ovarian cancer (OC) is one of the most fatal gynecological malignancies in the world and confers a poor 5-year survival rate. The present study was designed to discover novel prognostic markers for patients with OC in order to estimate disease metastasis or recurrence. Based on the large cohorts of...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285858/ https://www.ncbi.nlm.nih.gov/pubmed/32565963 http://dx.doi.org/10.3892/ol.2020.11557 |